Retracted: Calcitonin Gene-Related Peptide (CGRP) Antagonists: A comprehensive review of safety, efficacy and prescribing information.

Omaer A, Aldosari FM, McGlamery E, Alrashed S, Wool S, Fazel MT

Open source

DOI
10.1111/jcpt.13445
Published
2022 Jan
Container
Journal of clinical pharmacy and therapeutics
Publisher
Not recorded
Open access
unknown

Credibility signals

serious concern Score 8/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/jcpt.13445,
  title = {Retracted: Calcitonin Gene-Related Peptide (CGRP) Antagonists: A comprehensive review of safety, efficacy and prescribing information.},
  author = {Omaer A and Aldosari FM and McGlamery E and Alrashed S and Wool S and Fazel MT},
  year = {2022},
  journal = {Journal of clinical pharmacy and therapeutics},
  doi = {10.1111/jcpt.13445},
  url = {https://doi.org/10.1111/jcpt.13445}
}

RIS

TY  - JOUR
TI  - Retracted: Calcitonin Gene-Related Peptide (CGRP) Antagonists: A comprehensive review of safety, efficacy and prescribing information.
AU  - Omaer A
AU  - Aldosari FM
AU  - McGlamery E
AU  - Alrashed S
AU  - Wool S
AU  - Fazel MT
PY  - 2022
JO  - Journal of clinical pharmacy and therapeutics
DO  - 10.1111/jcpt.13445
UR  - https://doi.org/10.1111/jcpt.13445
ER  - 

APA

A, O., FM, A., E, M., S, A., S, W., & MT, F. (2022). Retracted: Calcitonin Gene-Related Peptide (CGRP) Antagonists: A comprehensive review of safety, efficacy and prescribing information.. Journal of clinical pharmacy and therapeutics. https://doi.org/10.1111/jcpt.13445

Source records